TipRanks on MSN

The narrowing pathway for biotech securities fraud claims: Lessons from Outlook Therapeutics

Litigation Trend Analysis The December 23, 2025 decision in In re Outlook Therapeutics, Inc. Securities Litigation (D.N.J., Case No.
Business Insider

These are the 2 main takeaways for investors from a year where stocks popped and the economy dodged a recession, according to UBS

Stocks defied Wall Street's gloomy predictions this year. Equities' surprise rally should teach investors two key lessons heading into 2024, according to UBS. Growth, inflation, and headline-grabbing ...